Extract from the Register of European Patents

EP Citations: EP3215132

Cited inSearch
Type:Patent literature
Publication No.:WO2014093475  [Y]
 (ACORDA THERAPEUTICS INC et al.) [Y] 1-16 * in particular * * 3. SUMMARY OF THE INVENTION * * paragraph [0016] - paragraph [0025] * * 5.2 Impairments Treated in Accordance with the Invention * * 5.6 Combination treatments * * paragraph [0122] * * Claims *
Type:Patent literature
Publication No.:WO2014204933  [XPI]
 (ADAMAS PHARMACEUTICALS INC et al.) [XP] 2-4,6-12,16 * the whole document * * in particular * * Summary of the Invention * * the tables * * the examples * * the claims *[I] 1-16
Type:Non-patent literature
Publication information:[I]   CHAN HIU-FAI ET AL: "Amantadine improves gait in PD patients with STN stimulation", PARKINSONISM AND RELATED DISORDERS, ELSEVIER SCIENCE, OXFORD, GB, vol. 19, no. 3, 6 December 2012 (2012-12-06), pages 316 - 319, XP028984445, ISSN: 1353-8020, DOI: 10.1016/J.PARKRELDIS.2012.11.005 [I] 1-16 * the whole document * * in particular * * abstract * * 'Patients and Methods' * * 'Results' * * tables 1, 2 * * 'Discussion' *
DOI: http://dx.doi.org/10.1016/j.parkreldis.2012.11.005
Type:Non-patent literature
Publication information:[Y]   CORNELIU C. LUCA ET AL: "4-Aminopyridine improves freezing of gait in Parkinson's disease", JOURNAL OF NEUROLOGY - ZEITSCHRIFT FUER NEUROLOGIE, vol. 260, no. 10, 30 August 2013 (2013-08-30), DE, pages 2662 - 2664, XP055472353, ISSN: 0340-5354, DOI: 10.1007/s00415-013-7090-0 [Y] 1-16 * the whole document *
DOI: http://dx.doi.org/10.1007/s00415-013-7090-0
Type:Non-patent literature
Publication information:[XPI]   RAJESH PAHWA ET AL.: "Amantadine Extended Release for Levodopa-induced Dyskinesia in Parkinson's Disease (EASED Study)", MOVEMENT DISORDERS, vol. 30, no. 6, 4 February 2015 (2015-02-04), pages 788 - 795, XP009505171 [XP] 2-4,6-12,16 * the whole document * * in particular * * abstract * * 'Design' * * 'Results' * * Discussion *[I] 1-16
DOI: http://dx.doi.org/10.1002/mds.26159
Type:Non-patent literature
Publication information:[XP]   ADAMAS PHARMACEUTICALS, INC: "Safety and Efficacy of ADS-5102 in Patients With Multiple Sclerosis and Walking Impairment", 15 June 2015 (2015-06-15), XP002780811, Retrieved from the Internet [retrieved on 20180504] [XP] 1-16 * the whole document *
Type:Non-patent literature
Publication information:[XI]   ADAMAS PHARMACEUTICALS, INC.: "Extended Release Amantadine Safety and Efficacy Study in Levodopa-Induced Dyskinesia (EASED Study) (EASED)", 19 July 2011 (2011-07-19), XP002780812, Retrieved from the Internet [retrieved on 20150504] [X] 2-4,6-12,16 * the whole document *[I] 1-16
Cited inInternational search
Type:Patent literature
Publication No.:WO2006053067  [XY]
 (PRESTWICK PHARMACEUTICALS INC et al.) [X] 1-2 * abstract; pg5, In16-17; pg7, 28-29; pg8, In7, 14 *[Y] 3-4, 9-13
Type:Patent literature
Publication No.:US2011189273  [Y]
 (WENT GREGORY T et al.) [Y] 3-4, 9-13 * para [0013], [0024], [0028], [0030], [0074], [0086] *
Type:Patent literature
Publication No.:US2014179797  [Y]
 (WENT GREGORY T et al.) [Y] 1-4, 9-13 * para [0030], [0045], [0072] *
Type:Patent literature
Publication No.:US2008279819  [Y]
 (WENT GREGORY T et al.) [Y] 1-4, 9-13 * para [0017]-[0019] *
Cited inExamination
Type:Non-patent literature
Publication information:  NICHOLAS RICHARD ET AL: "Multiple sclerosis", CLINICAL EVIDENCE, BMJ, UK, vol. 2012, 10 February 2012 (2012-02-10), XP009519419, ISSN: 1752-8526 [I] 1-16 * the whole document * * in particular * * abstract * * 'Patients and Methods' * * 'Results' * * tables 1, 2 * * 'Discussion' *
Cited inby applicant
Type:Patent literature
Publication No.:US2011189273  
Type:Patent literature
Publication No.:US5358721  
Type:Patent literature
Publication No.:US6217905  
Type:Patent literature
Publication No.:US8574626  
Type:Patent literature
Publication No.:US6194000  
Type:Patent literature
Publication No.:US2006252788  
Type:Patent literature
Publication No.:US2006189694  
Type:Patent literature
Publication No.:US2006142398  
Type:Patent literature
Publication No.:US2008227743  
Type:Patent literature
Publication No.:US8741343  
Type:Patent literature
Publication No.:US2015045446  
Type:Patent literature
Publication No.:US2015051292  
Type:Patent literature
Publication No.:US2014242163  
Type:Non-patent literature
Publication information:  GRACIES JMOLANOW CW: "Neuropsycho-pharmacology: the Fifth Generation of Progress", 2002, AMERICAN COLLEGE OF NEUROPSYCHO-PHARMACOLOGY, article "Current and Experimental Therapeutics of Parkinson's Disease", pages: 1802
Type:Non-patent literature
Publication information:  JACKSON ET AL., BULL. PAN AM. HEALTH ORG., vol. 147, 1967, pages 595 - 603
Type:Non-patent literature
Publication information:  JACKSON, JAMA, vol. 235, no. 25, 1976, pages 2739 - 2742
Type:Non-patent literature
Publication information:  HAYDEN, AAC, vol. 23, no. 3, 1983, pages 458 - 464
Type:Non-patent literature
Publication information:  PARKES ET AL., LANCET, vol. 1, 1970, pages 259 - 62
Type:Non-patent literature
Publication information:  CHAN ET AL., PARKINSONISM AND RELATED DISORDERS, vol. 19, 2013, pages 316 - 9
Type:Non-patent literature
Publication information:  MOREAU ET AL., LANCET NEUROLOGY, vol. 11, 2012, pages 589 - 96
Type:Non-patent literature
Publication information:  ESPAY ET AL., NEUROLOGY, vol. 76, 2011, pages 1256 - 62
Type:Non-patent literature
Publication information:  GOODMAN ET AL., LANCET, vol. 373, 2009, pages 732 - 8
Type:Non-patent literature
Publication information:  LUCA ET AL., NEUROLOGY, vol. 84, no. 14, 2015